192 related articles for article (PubMed ID: 13247268)
21. [Primary results in the combination of d-fructopyranosidase with strophanthin K in therapy of heart disease].
PUECH A; COMBIER C; CARLI N; PUECH P
Montp Med; 1953 Aug; 44(2):89-92. PubMed ID: 13119719
[No Abstract] [Full Text] [Related]
22. [Intravenous strophanthin therapy in heart diseases and its importance in general practice].
ASCHENBRENNER R
Dtsch Med Wochenschr; 1956 Dec; 81(50):1988-91. PubMed ID: 13397271
[No Abstract] [Full Text] [Related]
23. [Combined heart therapy with strophantin-theophylline].
BAUMANN C
Med Klin; 1954 Aug; 49(34):1328-9. PubMed ID: 13203009
[No Abstract] [Full Text] [Related]
24. [Critical remarks on intravenous strophanthin therapy].
MULLER R; SCHILD W
Arztl Wochensch; 1956 Nov; 11(46):1010-3. PubMed ID: 13394460
[No Abstract] [Full Text] [Related]
25. [Application of strophanthin in cardiotonic therapy].
STANULOVIC D
Med Pregl; 1952; (13-14-15):333. PubMed ID: 12982371
[No Abstract] [Full Text] [Related]
26. [Clinical use of strophanthin in the form of strophil].
HAGGENMILLER W; GESCHKE HJ
Munch Med Wochenschr; 1959 May; 101(19):848-51. PubMed ID: 13666753
[No Abstract] [Full Text] [Related]
27. [Influence of age on the effect of strophanthin in man].
MICHEL D; HARTLEB O; MARXHAUSEN E
Z Klin Med; 1958; 155(3):288-309. PubMed ID: 13604588
[No Abstract] [Full Text] [Related]
28. [Problem of an increase of strophanthin effect by cocarboxylase].
MICHEL D; HARTLEB O
Z Kreislaufforsch; 1959 Jun; 48(11-12):557-70. PubMed ID: 13676632
[No Abstract] [Full Text] [Related]
29. [Observations on the use of a new compound of nevanide and strophantin].
MUSCARI A; FOGLI M; DI MASSA R
Gazz Med Ital; 1953 Dec; 112(12):328-31. PubMed ID: 13151376
[No Abstract] [Full Text] [Related]
30. [Problems of cardiac glycoside therapy].
SEMMLER F
Med Klin; 1963 Apr; 58():553-60. PubMed ID: 13987909
[No Abstract] [Full Text] [Related]
31. [Treatment of conduction failures with smallest strophantin doses].
RENNEBERG W
Med Monatsschr; 1953 Apr; 7(4):237-9. PubMed ID: 13086509
[No Abstract] [Full Text] [Related]
32. [Letter: Digitalis or strophanthin?].
Schneider KW
Med Klin; 1974 Nov; 69(48):2006-7. PubMed ID: 4453295
[No Abstract] [Full Text] [Related]
33. [Oral strophanthin therapy, especially in heart disease in aged].
WIESEND W
Munch Med Wochenschr; 1956 Jun; 98(26):900-4. PubMed ID: 13348605
[No Abstract] [Full Text] [Related]
34. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
Apanasenko AA
Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
[No Abstract] [Full Text] [Related]
35. The danger of digitalis preparations, especially strophanthin.
KISCH B
Exp Med Surg; 1952; 10(1):69-76. PubMed ID: 14954893
[No Abstract] [Full Text] [Related]
36. [The effect of the glycoside strophanthin K on the ultrastructure of the cardiomyocytes in the pro-oxidant zone of the myocardium in rats with experimental heart failure].
Chernysh IN; Sadovnikov VB
Eksp Klin Farmakol; 1997; 60(4):29-31. PubMed ID: 9376752
[TBL] [Abstract][Full Text] [Related]
37. [Comparative hemodynamic studies with pure glycosides of Digitalis lanata and strophanthin].
GOTSCH K; BORKENSTEIN E; CLODI H
Z Kreislaufforsch; 1959 Jun; 48(11-12):547-57. PubMed ID: 13676631
[No Abstract] [Full Text] [Related]
38. [Small single doses of strophanthin combined with honey solutions in intravenous therapy of heart disease].
VON BOHM E
Ther Ggw; 1955 Sep; 94(9):344-5. PubMed ID: 13291276
[No Abstract] [Full Text] [Related]
39. [Digitalis and strophanthin glycosides in healthy persons: on the problem of early (preventive) digitalization].
Lydtin H; Schnelle K; Zöllner N
Med Klin; 1966 Mar; 61(9):349-51. PubMed ID: 4862655
[No Abstract] [Full Text] [Related]
40. [Cardiokinetic therapy in the aged. The role of strophanthin].
Cavalieri U; Bonaccorso O
Minerva Med; 1970 Feb; 61(15):700-4. PubMed ID: 5417562
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
